NU SKIN ENTERPRISES, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
NU SKIN ENTERPRISES, INC. (NUS) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $12.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-10
- NU SKIN ENTERPRISES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $6.06M, a 8.46% decline year-over-year.
- NU SKIN ENTERPRISES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $6.45M, a 0.20% increase year-over-year.
- NU SKIN ENTERPRISES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $6.74M, a 128.11% increase year-over-year.
- NU SKIN ENTERPRISES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $6.43M, a 27.56% decline year-over-year.
- NU SKIN ENTERPRISES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $26.23M, a 1.40% decline from fiscal 2024.
- NU SKIN ENTERPRISES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $26.60M, a 20.17% decline from fiscal 2023.
- NU SKIN ENTERPRISES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $33.32M, a 25.15% decline from fiscal 2022.
- NU SKIN ENTERPRISES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $44.52M, a 8.59% decline from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $12.51M 10-Q · filed 2026-08-10 | $19.25M derived: sum of 3 quarters · filed 2026-08-10 | $25.68M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $6.45M 10-Q · filed 2026-05-08 | $13.19M derived: sum of 2 quarters · filed 2026-05-08 | $19.62M derived: sum of 3 quarters · filed 2026-05-08 | $26.24M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $6.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $13.17M derived: sum of 2 quarters · filed 2026-02-13 | $19.79M derived: sum of 3 quarters · filed 2026-08-10 | $26.23M 10-K · filed 2026-02-13 |
| 2025-09-30 | $6.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $13.05M derived: sum of 2 quarters · filed 2026-08-10 | $19.48M 10-Q · filed 2025-11-07 | $22.44M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $6.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $13.05M 10-Q · filed 2026-08-10 | $16.01M derived: sum of 3 quarters · filed 2026-08-10 | $24.89M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $6.44M 10-Q · filed 2026-05-08 | $9.39M derived: sum of 2 quarters · filed 2026-05-08 | $18.27M derived: sum of 3 quarters · filed 2026-05-08 | $25.05M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $11.83M derived: sum of 2 quarters · filed 2026-02-13 | $18.61M derived: sum of 3 quarters · filed 2026-02-13 | $26.60M 10-K · filed 2026-02-13 |
| 2024-09-30 | $8.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $15.66M derived: sum of 2 quarters · filed 2025-11-07 | $23.64M 10-Q · filed 2025-11-07 | $32.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $6.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $14.77M 10-Q · filed 2025-08-08 | $23.12M derived: sum of 3 quarters · filed 2026-02-13 | $31.57M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $7.99M 10-Q · filed 2025-05-09 | $16.34M derived: sum of 2 quarters · filed 2026-02-13 | $24.79M derived: sum of 3 quarters · filed 2026-02-13 | $32.74M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $8.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $16.80M derived: sum of 2 quarters · filed 2026-02-13 | $24.75M derived: sum of 3 quarters · filed 2026-02-13 | $33.32M 10-K · filed 2026-02-13 |
| 2023-09-30 | $8.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $16.40M derived: sum of 2 quarters · filed 2024-11-08 | $24.97M 10-Q · filed 2024-11-08 | $36.23M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $7.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $16.52M 10-Q · filed 2024-08-09 | $27.79M derived: sum of 3 quarters · filed 2025-02-14 | $39.06M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $8.57M 10-Q · filed 2024-05-09 | $19.83M derived: sum of 2 quarters · filed 2025-02-14 | $31.11M derived: sum of 3 quarters · filed 2025-02-14 | $42.50M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $11.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $22.54M derived: sum of 2 quarters · filed 2025-02-14 | $33.94M derived: sum of 3 quarters · filed 2025-02-14 | $44.52M 10-K · filed 2025-02-14 |
| 2022-09-30 | $11.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $22.67M derived: sum of 2 quarters · filed 2023-11-02 | $33.25M 10-Q · filed 2023-11-02 | $41.25M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $11.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $21.98M 10-Q · filed 2023-08-02 | $29.98M derived: sum of 3 quarters · filed 2024-02-15 | $43.80M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $10.58M 10-Q · filed 2023-05-04 | $18.58M derived: sum of 2 quarters · filed 2024-02-15 | $32.41M derived: sum of 3 quarters · filed 2024-02-15 | $45.99M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $21.82M derived: sum of 2 quarters · filed 2024-02-15 | $35.41M derived: sum of 3 quarters · filed 2024-02-15 | $48.70M 10-K · filed 2024-02-15 |
| 2021-09-30 | $13.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $27.41M derived: sum of 2 quarters · filed 2022-11-03 | $40.70M 10-Q · filed 2022-11-03 | $52.78M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $13.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $26.88M 10-Q · filed 2022-08-05 | $38.95M derived: sum of 3 quarters · filed 2023-02-16 | |
| 2021-03-31 | $13.30M 10-Q · filed 2022-05-05 | $25.37M derived: sum of 2 quarters · filed 2023-02-16 | ||
| 2020-12-31 | $12.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $46.16M 10-K · filed 2023-02-16 | ||
| 2020-09-30 | $34.09M 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $44.46M 10-K · filed 2022-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |